T
TScan Therapeutics Inc
NASDAQ:TCRX
TScan Therapeutics Inc
NASDAQ:TCRX
Price:
1.095
USD
4.29%
Market Closed
Market Cap:
$62.1m
Cash Flow Statement
Cash Flow Statement
TScan Therapeutics Inc
TScan Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(26)
|
(29)
|
(34)
|
(42)
|
(49)
|
(57)
|
(61)
|
(62)
|
(66)
|
(73)
|
(82)
|
(88)
|
(89)
|
(97)
|
(104)
|
(111)
|
(127)
|
(131)
|
(137)
|
(143)
|
|
| Depreciation & Amortization |
1
|
1
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
5
|
6
|
6
|
5
|
5
|
5
|
5
|
4
|
4
|
3
|
3
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
6
|
7
|
8
|
10
|
11
|
12
|
12
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
5
|
5
|
6
|
6
|
5
|
5
|
6
|
6
|
8
|
8
|
8
|
10
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
|
| Change in Working Capital |
21
|
18
|
(3)
|
(4)
|
(6)
|
(9)
|
(9)
|
(12)
|
(10)
|
(8)
|
(8)
|
24
|
18
|
19
|
22
|
(6)
|
5
|
1
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
(3)
N/A
|
(8)
-160%
|
(34)
-331%
|
(42)
-23%
|
(49)
-17%
|
(59)
-21%
|
(62)
-5%
|
(65)
-5%
|
(67)
-3%
|
(70)
-5%
|
(79)
-12%
|
(54)
+32%
|
(61)
-14%
|
(67)
-9%
|
(71)
-6%
|
(107)
-50%
|
(111)
-3%
|
(119)
-8%
|
(126)
-6%
|
(131)
-4%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(4)
|
(6)
|
(10)
|
(9)
|
(10)
|
(8)
|
(5)
|
(5)
|
(4)
|
(5)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(5)
|
(5)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(60)
|
(58)
|
(21)
|
(54)
|
(75)
|
(49)
|
(71)
|
12
|
127
|
|
| Cash from Investing Activities |
(4)
N/A
|
(6)
-42%
|
(10)
-60%
|
(9)
+5%
|
(10)
-9%
|
(8)
+24%
|
(5)
+27%
|
(5)
+8%
|
(4)
+16%
|
(5)
-7%
|
(3)
+32%
|
(64)
-1 986%
|
(61)
+5%
|
(24)
+61%
|
(57)
-140%
|
(78)
-37%
|
(53)
+33%
|
(75)
-43%
|
7
N/A
|
122
+1 664%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
100
|
100
|
190
|
190
|
90
|
90
|
0
|
0
|
0
|
136
|
135
|
135
|
136
|
162
|
163
|
193
|
0
|
32
|
31
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
29
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
(1)
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
0
N/A
|
100
+34 279%
|
99
-1%
|
190
+92%
|
190
+0%
|
90
-52%
|
91
+1%
|
29
-68%
|
29
0%
|
29
0%
|
165
+463%
|
136
-18%
|
135
0%
|
136
+0%
|
162
+19%
|
163
+1%
|
209
+28%
|
208
0%
|
47
-78%
|
45
-3%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
(7)
N/A
|
86
N/A
|
56
-35%
|
139
+150%
|
131
-6%
|
24
-82%
|
24
+0%
|
(41)
N/A
|
(41)
-2%
|
(45)
-9%
|
83
N/A
|
18
-79%
|
13
-25%
|
45
+237%
|
33
-26%
|
(22)
N/A
|
45
N/A
|
14
-70%
|
(73)
N/A
|
36
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(14)
-91%
|
(43)
-213%
|
(51)
-17%
|
(59)
-15%
|
(66)
-13%
|
(67)
-1%
|
(70)
-4%
|
(71)
-1%
|
(75)
-5%
|
(82)
-10%
|
(58)
+29%
|
(65)
-12%
|
(70)
-9%
|
(75)
-7%
|
(111)
-48%
|
(115)
-4%
|
(124)
-8%
|
(131)
-6%
|
(136)
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
